Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial
Saved in:
Format: | Book |
---|---|
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RETRACTED ARTICLE: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial
by: Mohamed Rezk, et al.
Published: (2020) -
Expression of Concern: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial
Published: (2022) -
Oral labetalol compared to oral nifedipine for postpartum hypertension: A randomized controlled trial
by: Kathryn J. Sharma, et al.
Published: (2017) -
The comparison of side effects of methyldopa, amlodipine, and metoprolol in pregnant women with chronic hypertension
by: Masoumeh Ghafarzadeh, et al.
Published: (2020) -
Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials
by: Hui-Zhen Wu, et al.
Published: (2022)